Trachoma
Trachoma
Disease History, Characteristics, and Transmission
Introduction
Trachoma, also called granular conjunctivitis and Egyptian ophthalmia, is a contagious bacterial disease of the eye caused by the bacterium Chlamydia trachomatis. Flies become infected when they lay eggs on human feces lying in soil. The infection occurs when a host fly, infected with the bacterium, bites a human. A fly can also become a host and harbor the bacteria when it makes direct contact with eye, nose, or throat secretions from an infected person. The bacterium can also be carried directly to humans from contaminated hands byfomites (objects contaminated with infective material) such as clothing. The disease is reported as one of the leading infectious causes of blindness.
Disease History, Characteristics, and Transmission
The International Trachoma Initiate (ITI) states that trachoma is one of the oldest infectious diseases known to humankind, and was reported as far back as ancient Egypt. General improvements in public health and sanitation have eliminated trachoma from most industrialized nations such as those in North America and Europe. However, it continues to infect people at high rates in underdeveloped and developing countries, especially in the poorest areas of Africa, Asia, Australia, Latin America, and the Middle East.
An incubation period of about five to 12 days occurs before the eye becomes inflamed. Then, additional symptoms occur, including pus discharge, eyelid swelling, eye tearing, and light sensitivity. Within a few weeks, more symptoms begin to appear including chronic swelling (such as swelling of lymph nodes in front of the ears), eye blisters, cornea clouding, and cornea scarring. Extensive damage to the cornea can eventually lead to blindness.
Scope and Distribution
The ITI estimates that about eight million people are visually impaired due to trachoma and about 84 million people in 55 endemic countries suffer active symptoms. The World Health Organization (WHO) states that about 3.6 million people are blind from trachoma.
Trachoma occurs most commonly among populations living in overcrowded conditions and with limited contact to clean water and health care facilities such as in undeveloped villages in northern Africa. Children and women who take care of children are most susceptible to trachoma. Children between the ages of three and five years, according to the WHO, are most at risk of all groups of children. When infected early in life, the person may not notice the degradation in sight until adulthood.
Because close personal contact allows easier transmission of the disease, the ITI states that in many crowded African communities it is so prevalent that trachoma is considered a regular part of life. In the United States and other technologically advanced countries, trachoma is rare, but can occur in populations living in extreme poverty and crowdedness, and with poor hygienic conditions.
Treatment and Prevention
According to the National Library of Medicine (NLM), of the National Institutes of Health (NIH), symptoms start as an apparent irritation near the eye, what is sometimes called conjunctivitis (commonly called pink eye). Soon, hard pimples or granular outgrowths appear on the inner surface of the eyelids and inflammation occurs on its membrane.
If left untreated, scar tissue develops on the inside of the eyelid. Such scarring in children is usually not noticeable until later in the adult years. Formation of scarring eventually forces the eyelid to curve inward and the eyelashes to scrape the eye. Severe infection of the cornea can later occur. This activity can cause eye ulcers, which further cause scarring and vision problems. Eventually, slow and painful blindness develops over many years.
In the early stage of the infection, trachoma responds well to oral or topical antibiotics such as azithromycin, doxycycline, and erythromycin. Officials from NLM/NIH report that people who receive early treatment for trachoma before scarring and lid deformities occur have excellent chances to be cured. WHO recommends using oral eye ointments such as azithromycin and tetracycline to control trachoma.
WORDS TO KNOW
FOMITE: A fomite is an object or a surface to which an infectious microorganism such as bacteria or viruses can adhere and be transmitted. Transmission is often by touch.
HOST: Organism that serves as the habitat for a parasite, or possibly for a symbiont. A host may provide nutrition to the parasite or symbiont, or simply a place in which to live.
MORBIDITY: The term “morbidity” comes from the Latin word “morbus,” which means sick. In medicine it refers not just to the state of being ill, but also to the severity of the illness. A serious disease is said to have a high morbidity.
According to WHO, relief from trachoma can be attained by following the SAFE strategy: surgery, anti-biotics, facial cleanliness, and environmental improvement. Thus, surgery can be performed to correct advanced problems related to the disease. Early treatment with antibiotics can prevent long-term complications. Good hygiene should be consistently and thoroughly practiced such as washing of the face in order to reduce transmission. Access to clean water and improved sanitation facilities (especially the safe disposal of human and animal feces) also greatly help to reduce the occurrence and severity of the disease.
In addition, regular eye examinations can pinpoint abnormal redness on the white areas of the eyes, scarring on the inside of the upper eyelid, and improper blood vessel growth on the corneas. Laboratory tests, especially the polymerase chain reaction (PCR) technique, are used to identify the bacterium that causes trachoma. Such tests, however, are usually too costly for use in the poorest areas of the world where trachoma occurs the most.
Impacts and Issues
The infection often results in significant morbidity (ill effects arising from a state of disease), striking people during their productive working years. According to WHO, women are two to four times more likely to become blind after becoming infected with trachoma than men. Often they cannot take care of themselves and their children when infected by the disease, especially when they are blinded. It is often the case that the oldest daughter, or another child, is taken out of school to tend to family needs. Because of the child's incomplete education, she/he is then unable to earn a living outside the family unit, and is restricted to providing care to the family. This vicious cycle continues in the future by keeping families, and sometimes entire villages, in poverty. Consequently, ITI reports that about $2.9 billion (in U.S. currency) is lost worldwide annually in human productivity because of trachoma.
IN CONTEXT: DISEASE IN DEVELOPING NATIONS
The CDC assists the World Health Organization in reducing the occurrence of trachoma, and asserts that major declines are now found in those countries associated with multifaceted control programs. The CDC reports that “WHO has initiated a global campaign for the elimination of blindness due to trachoma, that recommends a strategy including antibiotics, improved personal and community hygiene and sanitation, and surgery to correct trichiasis. Campaign challenges include: establishing surveillance for endemic trachoma, determining when mass treatment with antibiotics is necessary (i.e., retreatment), determining the effectiveness of improved hygiene and sanitation at preventing a resurgence of endemic disease, monitoring for adverse effects of mass treatment with antibiotics…”
SOURCE: Centers for Disease Control and Prevention (CDC), Coordinating Center for Infectious Diseases, Division of Bacterial and Mycotic Diseases.
Common complications of trachoma include scarring of the conjunctiva (membrane under the eyes) and cornea, eye lid abnormalities, turned-in eyelashes, vision reductions, and, in severe cases, blindness. The prognosis for each individual person depends on the severity of the disease, the treatment used to combat it, and the number of times the eyes are re-infected. Persons with trachoma who are treated with the proper drugs and in the early stage of the infection are much more likely to fully recover. Severe symptoms can be often eliminated but eyesight, once lost, cannot be regained.
See AlsoAntibacterial Drugs; Bacterial Disease; Chlamydia Infection; Handwashing.
BIBLIOGRAPHY
Books
Bellenir, Karen, ed. Infectious Diseases Sourcebook. Detroit, MI: Omnigraphics, 2004.
Parker, James N. The Official Patient's Sourcebook on Trachoma. San Diego, CA: Icon Health Publications, 2002.
Periodicals
Mabey, D.C., A. Foster, and A.W. Solomon. “Trachoma.” Lancet. 362 (9379) (July 2003): 223–229.
Web Sites
International Trachoma Initiative. “Trachoma is a hidden disease.” 2005 <http://www.trachoma.org/trachoma.php> (accessed April 2, 2007).
National Library of Medicine, National Institutes of Health. “Trachoma.” September 22, 2006 <http://www.nlm.nih.gov/medlineplus/ency/article/001486.htm> (accessed April 2, 2007).
